Cross-border consolidation in healthcare services is likely to maintain momentum over the coming years, favored by various economic drivers. However, internationalization requires strategies adapted to regional contexts.
Photos: Olivier Hess
- Challenge: Cross-border M&A is gaining importance for growth diversification and consolidation, for example in the acute care sector. International deals require strategies adapted to regional markets.
- Solution: Global players from mature as well as developing markets, such as IHH Healthcare, Mediclinic and Fresenius, have substantially expanded their geographic footprint in the last decade. At the same time, multinational operators are focusing on specific market environments in a more limited region.
- Results: Equity markets have given operators credit for their internationalization strategies, rewarding multi-market players with higher EV/EBITDA valuations. Strong growth perspectives in emerging countries and the risen awareness of healthcare as a long-term defensive investment could spur globalization in the coming years.
Bold movements expected
Cross-border consolidation in healthcare services is likely to maintain momentum over the coming years. For long-term success management strategies adapted to regional contexts are critical. This was demonstrated by the expert analyses and case studies discussed in April at the "Healthcare Business International 2017" conference in London, England.1 In recent years, the healthcare services industry has been characterized by a spate of corporate mergers and takeovers.
Hedley Goldberg, Managing Director at Rothschild, reports that in the record-breaking year of 2015 there were more than 300 transactions in the healthcare sector in Europe alone. And over 280 deals were made in 2016.2 And there are also signs of consolidation in many emerging markets. "I expect that we will see more bold movement by diverse players in the next five to ten years," said Goldberg. In many cases these will most likely be cross-border mergers and acquisitions.
Economic drivers of international investment
There are a myriad of reasons for internationalization. Healthcare services may, at its core, be a local industry, but operators of private hospitals in developed countries, for example, are increasingly trying to break out of their national markets – to develop new sources of income as well as to diversify regulatory risks and achieve beneficial economies of scale, such as savings on purchases and the exchange of best practices. Emerging markets in particular also offer attractive growth prospects for international investments. For example, by 2030 two-thirds of the world's middle class could be living in the Asia-Pacific regions, with correspondingly high demands for healthcare services, stresses Goldberg.
Healthcare expenditures often increase disproportionately with a growing per capita GDP. Financial investments in the healthcare sector are, therefore, considered to be profitable in the long run and relatively low-risk compared to other sectors. Accordingly, they are currently very appealing to investors, which in turn will further drive globalization. "There is a lot of money available," states Goldberg. Healthcare companies that operate internationally are already valued highly on the capital markets. The ratio between enterprise value and EBITDA for multinational players can be two to three turns of EBITDA higher than for companies that only operate within a single market.
Hospital chains are expanding their geographic footprint
Some examples of the trend towards international consolidation are large operators of private hospitals, like the Australian company Ramsay, the South African Mediclinic Group or the Malaysian healthcare group IHH Healthcare. Back in 2005 these companies generated 100 percent (Ramsay, Mediclinic) and 74 percent (IHH) of their revenue in their home markets, explained UBS healthcare expert Martin Henrichs. Today, thanks to numerous mergers and acquisitions, 43 (Ramsay), 69 (Mediclinic) and as much as 84 percent (IHH) of their revenue is generated outside of their home markets. IHH currently operates hospitals in twelve countries, including Singapore, India, Turkey, China, Iraq and Bulgaria.3
The latest acquisition of Spain’s largest private hospital company, Quironsalud, by Germany's Fresenius Group for approximately $6 billion is no less noteworthy.4 In addition, Fresenius subsidiary Fresenius Medical Care, which is the world's largest operator of dialysis clinics, recently acquired a majority stake in Australia's Cura Group with its 19 private day hospitals across Australia. As a consequence, Fresenius Medical Care not only gained a stronger foothold in Australia, but it also strengthened its portfolio to include outpatient ophthalmology and orthopedic surgeries, for example.5 The experts at the Healthcare Business International 2017 conference in London agreed a general trend in many countries towards outpatient and specialized hospitals could be observed.
Global players and regional champions
A key element in cross-border consolidation is that surrounding conditions of different countries have to be taken into account. "In any international expansion to a new geography, working with the right local management team is key to success," comments Henrichs. Disease burden, medical infrastructure, patient profiles as well as the regulatory and reimbursement framework can vary significantly from country to country. In addition, there are often language barriers and cultural peculiarities which need to be taken into account. “There is no one-size-fits-all approach for the internationalization of healthcare services”, says Henrichs. Instead, different business and reimbursement models will continue to coexist in the future and will create operators with different regional, national and international coverage profiles. "We will see global players as well as regional champions."
The hospital group Penta Hospitals International, which operates hospitals and clinics in Slovakia, Czech Republic and Poland, is one example of a regionally oriented company. "Healthcare remains the last untouched industry in Central Eastern Europe, sharing many common characteristics," stressed Attila Vegh, Chairman and CEO of Penta Hospitals International, in London.6 Characteristics for many countries in this region in particular are deficits in public healthcare budgets, extremely obsolete infrastructures and a high degree of market fragmentation, but also traditionally good medical training. Some doctors who emigrated to Western Europe after the fall of the Iron Curtain, for example, have meanwhile returned to their home countries in a "reverse brain drain". The willingness of the general public to pay for high quality healthcare services is also increasing. Vegh is convinced that "healthcare in Central Eastern Europe is ready for disruption." With this in mind, the company is planning to further expand its position as a multinational player by investing in modern technologies, quality standards and mergers. Penta wants to increase the number of its hospitals from 34 to a total of 50 by 2019.
About the Author
Martin Lindner is an award-winning science writer based in Berlin, Germany. After completing his medical studies and a doctoral thesis in the history of medicine, he went into journalism. His articles have appeared in many major German and Swiss newspapers and magazines.
About Siemens Healthineers
Our new name expresses our mission and what we stand for: Helping healthcare providers become more successful in caring for their patients.
Our new name is unique. It embodies our pioneering spirit and our engineering expertise in the healthcare industry. It reflects the fact that this industry is increasingly driven by the skills of individuals. It also contains a commitment and a promise to our customers that we will use our pioneering spirit and our engineering expertise to help drive their success.
1https://hbi2017.healthcarebusinessinternational.com (accessed 25 April 2017)
2Hedley Goldberg: Healthcare Services – the Global Financial Landscape. Presentation at the Healthcare Business International 2017 Conference, London, 4-5 April 2017
3Martin Henrichs: Private Acute Care –Today, tomorrow and in the future. Presentation at the Healthcare Business International 2017 Conference, London, 4-5 April 2017
4Reuters (5 September 2016) Fresenius buys Spanish hospital chain for 5.76 billion euro. https://hbi2017.healthcarebusinessinternational.com (accessed 27 April 2017)
5Reuters (3 February 2017) UPDATE 1 – FMC takes control of Australian outpatient treatment chain. http://www.reuters.com/article/fresenius-medi-acquisition-idUSL5N1FO1SB?type=companyNews (accessed 27 April 2017)
6Attila Vegh: Building a Pan-Eastern European Hospital Chain. Presentation at the Healthcare Business International 2017 Conference, London, 4-5 April 2017
The statements by Siemens’ customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.